# Pioglitazone Versus Metformin in Type 2 Diabetes

> **NCT00815399** · PHASE4 · COMPLETED · sponsor: **University of Campania Luigi Vanvitelli** · enrollment: 150 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00815399
- **Lead sponsor:** University of Campania Luigi Vanvitelli
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2015-03
- **Final completion:** 2015-04
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2015-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00815399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00815399, "Pioglitazone Versus Metformin in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00815399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*